Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:36 pm Purchase |
2024-12-31 | 13G | Iterum Therapeutics plc ITRM |
Armistice Capital, LLC | 1,445,158 4.990% |
105,158 (+7.85%) |
Filing History |
| 2025-02-14 5:35 pm Purchase |
2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Armistice Capital, LLC | 3,529,006 4.990% |
2,770,121 (+365.03%) |
Filing History |
| 2025-02-14 5:35 pm Purchase |
2024-12-31 | 13G | T Stamp Inc. IDAI |
Armistice Capital, LLC | 1,397,878 4.990% |
1,397,878 (New Position) |
Filing History |
| 2025-02-14 5:35 pm Sale |
2024-12-31 | 13G | GeoVax Labs, Inc. GOVX |
Armistice Capital, LLC | 495,589 4.990% |
-450,548 (-47.62%) |
Filing History |
| 2025-02-14 5:34 pm Purchase |
2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Armistice Capital, LLC | 3,137,553 4.990% |
773,553 (+32.72%) |
Filing History |
| 2025-02-14 5:33 pm Sale |
2024-12-31 | 13G | Clene Inc. CLNN |
Armistice Capital, LLC | 419,101 4.990% |
-280,899 (-40.13%) |
Filing History |
| 2025-02-14 5:33 pm Sale |
2024-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Armistice Capital, LLC | 440,422 4.990% |
-238,108 (-35.09%) |
Filing History |
| 2025-02-14 5:32 pm Purchase |
2024-12-31 | 13G | Banzai International, Inc. BNZI |
Armistice Capital, LLC | 309,096 4.990% |
148,066 (+91.95%) |
Filing History |
| 2025-02-14 5:31 pm Purchase |
2024-12-31 | 13G | Mustang Bio, Inc. MBIO |
Armistice Capital, LLC | 5,106,287 9.990% |
5,106,287 (New Position) |
Filing History |
| 2025-02-14 5:30 pm Purchase |
2024-12-31 | 13G | Kura Oncology, Inc. KURA |
Armistice Capital, LLC | 5,800,000 7.460% |
5,800,000 (New Position) |
Filing History |
| 2025-02-14 5:30 pm Purchase |
2024-12-31 | 13G | Professional Diversity Network, Inc. IPDN |
Armistice Capital, LLC | 133,418 9.990% |
133,418 (New Position) |
Filing History |
| 2025-02-14 5:29 pm Purchase |
2024-12-31 | 13G | Intensity Therapeutics, Inc. INTS |
Armistice Capital, LLC | 1,126,868 8.130% |
1,126,868 (New Position) |
Filing History |
| 2025-02-14 5:28 pm Purchase |
2024-12-31 | 13G | Globus Maritime Limited GLBS |
Armistice Capital, LLC | 1,200,000 5.510% |
1,200,000 (New Position) |
Filing History |
| 2025-02-14 5:28 pm Sale |
2024-12-31 | 13G | Draganfly Inc. DPRO |
Armistice Capital, LLC | 480,794 8.860% |
-1,114,414 (-69.86%) |
Filing History |
| 2025-02-14 5:27 pm Purchase |
2024-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
Armistice Capital, LLC | 4,997,275 9.990% |
4,997,275 (New Position) |
Filing History |
| 2025-02-14 5:26 pm Purchase |
2024-12-31 | 13G | Bio-Path Holdings, Inc. BPTH |
Armistice Capital, LLC | 613,798 9.990% |
613,798 (New Position) |
Filing History |
| 2025-02-14 5:25 pm Sale |
2024-12-31 | 13G | BIO-key International, Inc. BKYI |
Armistice Capital, LLC | 164,235 4.990% |
-85,765 (-34.31%) |
Filing History |
| 2025-02-14 5:25 pm Sale |
2024-12-31 | 13G | Brainstorm Cell Therapeutics Inc. BCLI |
Armistice Capital, LLC | 299,548 4.990% |
-7,784,398 (-96.29%) |
Filing History |
| 2025-02-14 5:24 pm Purchase |
2024-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 5,396,000 9.880% |
196,000 (+3.77%) |
Filing History |
| 2025-02-14 5:23 pm Purchase |
2024-12-31 | 13G | Catheter Precision, Inc. VTAK |
Armistice Capital, LLC | 874,079 9.990% |
768,336 (+726.61%) |
Filing History |